Work

Inhibiting the PI3K signaling pathway: buparlisib as a new targeted option in breast carcinoma

Year: 2015

Type: review

Source: Clinical & Translational Oncology

DOI: 10.1007/s12094-015-1410-z

Authors: L. G. Estévez, E. García, M. Hidalgo

Institutions: HM Hospitales, Hospital Universitario Fundación Alcorcón, Spanish National Cancer Research Centre

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Novartis, Novartis Pharma

OpenAlex ID: W1895841947

FWCI: 0.065

Cites: 65

Cited by: 10

Related to: 10